Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 8
2018 6
2019 9
2020 9
2021 12
2022 6
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of leukocytoclastic vasculitis.
Fraticelli P, Benfaremo D, Gabrielli A. Fraticelli P, et al. Among authors: benfaremo d. Intern Emerg Med. 2021 Jun;16(4):831-841. doi: 10.1007/s11739-021-02688-x. Epub 2021 Mar 13. Intern Emerg Med. 2021. PMID: 33713282 Free PMC article. Review.
Biologics in Inflammatory Immune-mediated Systemic Diseases.
Moroncini G, Calogera G, Benfaremo D, Gabrielli A. Moroncini G, et al. Among authors: benfaremo d. Curr Pharm Biotechnol. 2017;18(12):1008-1016. doi: 10.2174/1389201019666171226152448. Curr Pharm Biotechnol. 2017. PMID: 29278213 Review.
Certolizumab pegol for the treatment of psoriasis.
Campanati A, Benfaremo D, Luchetti MM, Ganzetti G, Gabrielli A, Offidani A. Campanati A, et al. Among authors: benfaremo d. Expert Opin Biol Ther. 2017 Mar;17(3):387-394. doi: 10.1080/14712598.2017.1283401. Epub 2017 Feb 6. Expert Opin Biol Ther. 2017. PMID: 28165828 Review.
Biologics in Inflammatory and Immunomediated Arthritis.
Luchetti MM, Benfaremo D, Gabrielli A. Luchetti MM, et al. Among authors: benfaremo d. Curr Pharm Biotechnol. 2017;18(12):989-1007. doi: 10.2174/1389201019666171226151852. Curr Pharm Biotechnol. 2017. PMID: 29278210 Review.
Putative functional pathogenic autoantibodies in systemic sclerosis.
Benfaremo D, Svegliati Baroni S, Manfredi L, Moroncini G, Gabrielli A. Benfaremo D, et al. Eur J Rheumatol. 2020 Oct;7(Suppl 3):S181-S186. doi: 10.5152/eurjrheum.2020.19131. Epub 2020 Oct 1. Eur J Rheumatol. 2020. PMID: 33164733 Free PMC article. Review.
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.
Paolini C, Agarbati S, Benfaremo D, Mozzicafreddo M, Svegliati S, Moroncini G. Paolini C, et al. Among authors: benfaremo d. Int J Mol Sci. 2022 Mar 31;23(7):3904. doi: 10.3390/ijms23073904. Int J Mol Sci. 2022. PMID: 35409263 Free PMC article. Review.
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study.
Campochiaro C, De Luca G, Lazzaroni MG, Armentaro G, Spinella A, Vigone B, Ruaro B, Stanziola A, Benfaremo D, De Lorenzis E, Moccaldi B, Bosello SL, Cuomo G, Beretta L, Zanatta E, Giuggioli D, Del Papa N, Airo P, Confalonieri M, Moroncini G, Dagna L, Matucci-Cerinic M. Campochiaro C, et al. Among authors: benfaremo d. RMD Open. 2023 Feb;9(1):e002850. doi: 10.1136/rmdopen-2022-002850. RMD Open. 2023. PMID: 36813476 Free PMC article.
Current Take on Systemic Sclerosis Patients' Vaccination Recommendations.
Murdaca G, Noberasco G, Olobardi D, Lunardi C, Maule M, Delfino L, Triggiani M, Cardamone C, Benfaremo D, Moroncini G, Vacca A, Susca N, Gangemi S, Quattrocchi P, Sticchi L, Icardi G, Orsi A. Murdaca G, et al. Among authors: benfaremo d. Vaccines (Basel). 2021 Dec 2;9(12):1426. doi: 10.3390/vaccines9121426. Vaccines (Basel). 2021. PMID: 34960174 Free PMC article. Review.
53 results